Efficacy and safety of RCEOP chemotherapy in patients with diffuse large cell lymphoma (DLCL) not fit for anthracyclines are comparable to RCHOP
Abdulwahid, D. Arbuthnot, C. Paneesha, S. Jobanputra, S. Borg, A.
Abdulwahid, D.
Arbuthnot, C.
Paneesha, S.
Jobanputra, S.
Borg, A.
Citations
Altmetric:
Affiliation
University Hospitals Coventry and Warwickshire NHS Trust; South Warwickshire University NHS Foundation Trust; Heart of England Foundation NHS Trust, Birmingham
Other Contributors
Publication date
2016-04-12
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Poster abstract 198 in the section 'Lymphoid Malignancy – Clinical' of the XXXVI World Congress of the International Society of Hematology, hosted by the British Society for Haematology, 18–21 April 2016, Glasgow, UK.
Citation
Abdulwahid D, Arbuthnot C, Paneesha S, Jobanputra S, Borg A. Efficacy and safety of RCEOP chemotherapy in patients with diffuse large cell lymphoma (DLCL) not fit for anthracyclines are comparable to RCHOP. Br J Haematol. 2016 Apr;173(Suppl 1):83. doi: 10.1111/bjh.14019.
Type
Conference Output